The dmLT-specific ALS response rates were high in both the 5 μg and 25 μg oral dmLT groups with response rates of 92% and 100% respectively for IgG and 100% in both groups for IgA. The gene discussed is CD79A; the disease is amyotrophic lateral sclerosis.